
The CELLEBRATE trial is aiming to provide additional evidence to support the safety and efficacy of iltamiocel.

The CELLEBRATE trial is aiming to provide additional evidence to support the safety and efficacy of iltamiocel.

"This trial will be the benchmark for research reporting in the future," says Melissa R. Kaufman, MD, PhD, FACS.

In this episode, guideline chair Melissa Kaufman, MD, PhD, FACS, highlights key points from the new AUA GSM guideline and illustrates its impact for clinical management of this condition.

Published: May 9th 2025 | Updated: